Sponsor Pipeline

Shenzhen Hemogen Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
1
Early Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06655662 Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia… Β-thalassemia Recruiting
Early Phase 1
NCT05745532 Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells… β-thalassemia Recruiting
NCT05851105 the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With… α-thalassemia Recruiting
NCT05864170 the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With… β-thalassemia Recruiting
Disease Areas
Thalassemia (4)
Get alerts when Shenzhen Hemogen's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free